Ansell: bad news, good news

Ansell has had a rough start to the year, but there's still plenty to like about the company – and the share price.

In Ansell: Interim result 2015 from 10 Feb 15 (Sell – $24.06), we noted the challenging macro environment facing the glove and condom maker in the year ahead. Ultimately, we said, ‘as many of Ansell’s customers have learnt, hope is not a strategy – you need protection ... until a margin of safety returns, we’re downgrading to SELL'.

The margin of safety has arrived. The stock fell 20% following a profit downgrade and the share price is now down 36% since that review. Before we jump on board, though, let’s take a look at the bad news.


SMS Code Sent…

We have sent you a code via SMS to {{user.DayPhone}}

please enter this code below to activate your membership

If you didn't receive SMS code please

Log in to access this content

Looks you are already a member. Please enter your password to proceed

Hi {{ user.FirstName }}

Verify your mobile number to unlock a FREE trial

Looks like you've already taken a free trial

Please sign up for full access

Updating information

Please wait ...

Related Articles